Atrial fibrillation/flutter and Salivary hypersecretion

Summary:

Salivary hypersecretion is found among people with Atrial fibrillation/flutter, especially for people who are male, 60+ old.

The study analyzes which people have Salivary hypersecretion with Atrial fibrillation/flutter. It is created by eHealthMe based on reports of 49 people who have Atrial fibrillation/flutter from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,362 drugs and 3,844 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

What is Salivary hypersecretion?

Salivary hypersecretion (excess saliva secretion) is found to be associated with 781 drugs and 1,338 conditions by eHealthMe. Check the latest studies of Salivary hypersecretion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

49 people who have Atrial Fibrillation/Flutter and Salivary Hypersecretion are studied.

Would you have Salivary hypersecretion when you have Atrial fibrillation/flutter?

Gender of people who have Atrial Fibrillation/Flutter and experienced Salivary Hypersecretion *:

female: 46.81 %
male: 53.19 %

Age of people who have Atrial Fibrillation/Flutter and experienced Salivary Hypersecretion *:

Common co-existing conditions for these people *:

High Blood Cholesterol: 10 people, 20.41%
High Blood Pressure: 9 people, 18.37%
Cardiac Failure: 6 people, 12.24%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 10.20%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 10.20%
Type 2 Diabetes: 4 people, 8.16%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 6.12%
Indigestion: 3 people, 6.12%
Parkinson's Disease: 3 people, 6.12%
Constipation: 2 people, 4.08%

Common drugs taken by these people *:

Common symptoms for these people *:

Weakness: 13 people, 26.53%
Weight Decreased: 10 people, 20.41%
Nausea (feeling of having an urge to vomit): 10 people, 20.41%
Swallowing Difficulty: 9 people, 18.37%
Fall: 8 people, 16.33%
Dizziness: 8 people, 16.33%
Diarrhea: 7 people, 14.29%
Tremor (trembling or shaking movements in one or more parts of your body): 7 people, 14.29%
Speech Disorder: 7 people, 14.29%
Headache (pain in head): 7 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Salivary hypersecretion?

- Check whether Salivary hypersecretion is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Salivary hypersecretion and Atrial fibrillation/flutter, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.